
Sbrise Pharmaceuticals Private Limited
About Sbrise Pharmaceuticals Private Limited
Data last updated:
Sbrise Pharmaceuticals Private Limited was a private limited company based in Baramati, Maharashtra, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 24 December 2014.
The company was registered with the Registrar of Companies (ROC), Pune, under CIN U74900PN2014PTC153551. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Bhushan Balkrishna Girme and Sarika Bhushan Girme.
Its last annual general meeting (AGM) was held on 30 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office was at G.No.133/1 P.No. 22 Gala No. 04 Sai Residency Jalochi Shivaji Nagar, Baramati, Maharashtra, India – 413102.
As per the financials filed for FY 2017, the company reported a revenue of ₹1.73 Lakh. For the same year it recorded a net loss of ₹1.2 Lakh (net margin -69.4%) and EBITDA of -₹1.63 Lakh (EBITDA margin -94.2%).
Company details
Contact details
Sbrise Pharmaceuticals Private Limited's registered office is in Baramati, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressG.No.133/1 P.No. 22 Gala No. 04 Sai Residency Jalochi Shivaji Nagar, Baramati, Maharashtra, India – 413102
- IndustryTrading, Wholesale, Other Wholesale
To see the full contact details of Sbrise Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Sbrise Pharmaceuticals Private Limited
FY 2018 filings availableSbrise Pharmaceuticals Private Limited reported revenue of ₹1.73 Lakh for FY 2017.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹1.73 Lakh | ||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹1.63 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹1.2 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -94.2% | ||
| Net Profit Margin | -69.4% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Sbrise Pharmaceuticals Private Limited, buy the company report.
Board of directors of Sbrise Pharmaceuticals Private Limited
Sbrise Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhushan Balkrishna Girme | Director | 24 Dec 2014 | 11 Years 10 Months | As last reported |
| Sarika Bhushan Girme | Director | 24 Dec 2014 | 11 Years 10 Months | As last reported |
Auditor
Sbrise Pharmaceuticals Private Limited is audited by DEVGIRIKAR & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DEVGIRIKAR & ASSOCIATES | FY 2017 | 140495W |
Shareholding
The shareholding of Sbrise Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Sbrise Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sbrise Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sbrise Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sbrise Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Sbrise Pharmaceuticals Private Limited, buy the company report.
Recent activity
Sbrise Pharmaceuticals Private Limited has 2 board changes on record since 2014: 2 appointments. The latest: Bhushan Balkrishna Girme was appointed as Director on 24 Dec 2014.
Frequently asked questions
Sbrise Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Sbrise Pharmaceuticals was a private limited company based in Baramati, Maharashtra, India. The company worked in wholesale, within the trading industry. It was incorporated on 24 December 2014 and is registered under CIN U74900PN2014PTC153551. The company has been struck off by the Registrar of Companies and is no longer operational.
Sbrise Pharmaceuticals had 2 directors:
- Bhushan Balkrishna Girme - Director
- Sarika Bhushan Girme - Director
The CIN (Corporate Identification Number) of Sbrise Pharmaceuticals is U74900PN2014PTC153551. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Sbrise Pharmaceuticals is at G.No.1331 P.No. 22 Gala No. 04 Sai Residency Jalochi Shivaji Nagar, Baramati, Maharashtra, India – 413102.
Sbrise Pharmaceuticals was incorporated on 24 December 2014. It is registered with the Registrar of Companies, Pune.
The latest financial statements of Sbrise Pharmaceuticals on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 30 September 2018. Year-wise statements from 2015 are in the company report.
No. Sbrise Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
Sbrise Pharmaceuticals operated in the trading industry, in the wholesale segment. It worked in this industry before it was struck off.
Bhushan Balkrishna Girme was appointed as Director on 24 Dec 2014. Sarika Bhushan Girme was appointed as Director on 24 Dec 2014.

